Overview

Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder

Status:
Not yet recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and potential efficacy of psilocybin-assisted psychotherapy to reduce post-traumatic stress disorder (PTSD) severity in a sample of individuals with PTSD.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Psilocybin